[-2]PROPSA PREDICTS BIOPSY RECLASSIFICATION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

被引:0
|
作者
Tosoian, Jeffrey
Isharwal, Sumit
Feng, Zhaoyong
Makarov, Danil
Landis, Patricia
Veltri, Robert
Trock, Bruce
Epstein, Jonathan
Partin, Alan
Sokoll, Lori
Carter, H. B.
Loeb, Stacy
机构
来源
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词
D O I
10.1016/j.juro.2011.02.2570
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
2323
引用
收藏
页码:E931 / E932
页数:2
相关论文
共 50 条
  • [31] THE ROLE OF SURVEILLANCE BIOPSY WITH NO CANCER AS A PROGNOSTIC MARKER FOR RECLASSIFICATION: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS)
    Kearns, James
    Faino, Anna
    Newcomb, Lisa
    Brooks, James
    Carroll, Peter
    Dash, Atreya
    Ellis, William
    Fabrizio, Michael
    Gleave, Martin
    Morgan, Todd
    Nelson, Peter
    Thompson, Ian
    Wagner, Andrew
    Zheng, Yingye
    Lin, Daniel
    JOURNAL OF UROLOGY, 2017, 197 (04): : E557 - E557
  • [32] Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer
    Alam, Ridwan
    Carter, H. Ballentine
    Landis, Patricia
    Epstein, Jonathan I.
    Mamawala, Mufaddal
    JOURNAL OF UROLOGY, 2015, 193 (06): : 1950 - 1955
  • [33] Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
    Carter, H. Ballentine
    Helfand, Brian
    Mamawala, Mufaddal
    Wu, Yishuo
    Landis, Patricia
    Yu, Hongjie
    Wiley, Kathleen
    Na, Rong
    Shi, Zhuqing
    Petkewicz, Jacqueline
    Shah, Sameep
    Fantus, Richard J.
    Novakovic, Kristian
    Brendler, Charles B.
    Zheng, S. Lilly
    Isaacs, William B.
    Xu, Jianfeng
    EUROPEAN UROLOGY, 2019, 75 (05) : 743 - 749
  • [34] ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program
    Isharwal, Sumit
    Makarov, Danil V.
    Sokoll, Lori J.
    Landis, Patricia
    Marlow, Cameron
    Epstein, Jonathan I.
    Partin, Alan W.
    Carter, H. Ballentine
    Veltri, Robert W.
    UROLOGY, 2011, 77 (03) : 763.e1 - 763.e6
  • [35] Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance
    Francisco, Ignacio F. San
    Rojas, Pablo A.
    DeWolf, William C.
    Morgentaler, Abraham
    BJU INTERNATIONAL, 2014, 114 (02) : 229 - 235
  • [36] WHAT PREDICTS LONG TERM SEXUAL DYSFUNCTION FOR MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER?
    Albaugh, Jeffrey
    Helfand, Brian
    Victorson, David
    Novakovic, Kristian
    Brendler, Charles
    Pruitt, Jaclyn
    Rabbitt, Sarah
    McGuire, Michael
    JOURNAL OF UROLOGY, 2013, 189 (04): : E571 - E571
  • [37] DISCORDANCE RATES OF BIOPSY TECHNIQUES AMONG MEN WITH PROSTATE CANCER THAT ARE CANDIDATES FOR ACTIVE SURVEILLANCE
    Linder, Brian
    Frank, Igor
    Umbreit, Eric
    Shimko, Mark
    Fernandez, Nicolas
    Rangel, Laureano
    Karnes, R. Jeffrey
    JOURNAL OF UROLOGY, 2012, 187 (04): : E887 - E887
  • [38] ASSOCIATION OF DIET AND NUTRIENT INTAKE WITH BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Su, Zhuo T.
    Mamawala, Mufaddal K.
    Landis, Patricia K.
    Kuczler, Morgan
    Gorin, Michael A.
    Pavlovich, Christian P.
    Trock, Bruce J.
    JOURNAL OF UROLOGY, 2020, 203 : E1287 - E1287
  • [39] The prognostic impact of a negative confirmatory biopsy in men on active surveillance for prostate cancer.
    Salari, Keyan
    Zlatev, Dimitar V.
    Kuppermann, David
    Preston, Mark A.
    Dahl, Douglas M.
    Efstathiou, Jason A.
    Blute, Michael L.
    Zietman, Anthony L.
    Feldman, Adam S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer
    Fakunle, Mary O.
    Cowan, Janet E.
    Washington III, Samuel L.
    Shinohara, Katsuto
    Nguyen, Hao G.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2025, 213 (01): : 34 - 39